Evidence map›Paper›PMID 31085155›Full record

ReviewHematology, transfusion and cell therapy

Proposal of treatment algorithm for immune thromocytopenia in adult patients of a hematology service at a referral center in Northeastern Brazil.

Rosângela de Albuquerque Ribeiro, Gentil Claudino de Galiza Neto, Amanda da Silva Furtado, Lucas Loiola Ponte Albuquerque Ribeiro, Marcela Sobreira Kubrusly, Elsie Sobreira Kubrusly

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Hematology, transfusion and cell therapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Impact ofDiagnostics (Basel, Switzerland) · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Rosângela de Albuquerque RibeiroHospital Universitário Walter Cantídio, Universidade Federal do Ceará (HUWC UFC), Fortaleza, CE, Brazil. Electronic address: rosangela.ar@uol.com.br.
Gentil Claudino de Galiza NetoHospital Universitário Walter Cantídio, Universidade Federal do Ceará (HUWC UFC), Fortaleza, CE, Brazil.
Amanda da Silva FurtadoHospital Universitário Walter Cantídio, Universidade Federal do Ceará (HUWC UFC), Fortaleza, CE, Brazil.
Lucas Loiola Ponte Albuquerque RibeiroUniversidade de Fortaleza (UNIFOR), Fortaleza, CE, Brazil.
Marcela Sobreira KubruslyCentro Universitário Christus (UNICHRISTUS), Fortaleza, CE, Brazil.
Elsie Sobreira KubruslyHospital Universitário Walter Cantídio, Universidade Federal do Ceará (HUWC UFC), Fortaleza, CE, Brazil; Centro Universitário Christus (UNICHRISTUS), Fortaleza, CE, Brazil.
Universidade Federal do Ceará · BRUnichristus · BRUniversidade de Fortaleza · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe management of adult (≥18 years) immune thrombocytopenia patients relies on platelet count, the risk of bleeding and presence of bleeding.

objectiveConfirming the diagnosis of immune thrombocytopenia and the start of therapy, our hematology service, a referral center, favors the establishment of this algorithm to treat those patients.

resultsPresentation, recently diagnosed or recurrence - group 1: life-threatening bleeding: high-dose intravenous immunoglobulins with methylprednisolone or dexamethasone. Hospitalization and platelet transfusion are considered. Group 2: Platelets <30×10

Indexed as

AdultsDrugImmuneTherapyThrombocytopenia

Identifiers

PMID31085155
PMCPMC6732411
OpenAlexW2912677196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.